89.31
price up icon1.42%   1.25
after-market アフターアワーズ: 90.00 0.69 +0.77%
loading
前日終値:
$88.06
開ける:
$87.65
24時間の取引高:
2.03M
Relative Volume:
1.14
時価総額:
$17.44B
収益:
$4.58B
当期純損益:
$870.87M
株価収益率:
20.30
EPS:
4.3988
ネットキャッシュフロー:
$945.58M
1週間 パフォーマンス:
+2.29%
1か月 パフォーマンス:
+5.64%
6か月 パフォーマンス:
+53.98%
1年 パフォーマンス:
+37.04%
1日の値動き範囲:
Value
$87.50
$89.56
1週間の範囲:
Value
$84.38
$89.56
52週間の値動き範囲:
Value
$53.56
$92.86

Incyte Corp Stock (INCY) Company Profile

Name
名前
Incyte Corp
Name
セクター
Healthcare (1143)
Name
電話
(302) 498-6700
Name
住所
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Name
職員
2,617
Name
Twitter
@Incyte
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
INCY's Discussions on Twitter

INCY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INCY
Incyte Corp
89.31 17.05B 4.58B 870.87M 945.58M 4.3988
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Incyte Corp Stock (INCY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-08-06 アップグレード Wells Fargo Equal Weight → Overweight
2025-08-01 開始されました Barclays Overweight
2025-06-16 アップグレード Stifel Hold → Buy
2025-03-18 ダウングレード Guggenheim Buy → Neutral
2025-03-18 ダウングレード William Blair Outperform → Mkt Perform
2024-12-17 開始されました UBS Neutral
2024-10-29 アップグレード BofA Securities Neutral → Buy
2024-10-01 開始されました Wolfe Research Outperform
2024-09-18 ダウングレード Truist Buy → Hold
2024-07-02 ダウングレード BMO Capital Markets Market Perform → Underperform
2024-05-23 開始されました Deutsche Bank Hold
2024-04-23 開始されました Cantor Fitzgerald Neutral
2024-02-23 開始されました Jefferies Buy
2024-02-14 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2023-12-13 アップグレード Leerink Partners Market Perform → Outperform
2023-12-04 アップグレード Guggenheim Neutral → Buy
2023-11-21 ダウングレード Goldman Buy → Neutral
2023-07-25 開始されました Citigroup Buy
2023-05-04 ダウングレード BofA Securities Buy → Neutral
2023-04-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-03-24 アップグレード SVB Securities Underperform → Market Perform
2023-01-31 開始されました Piper Sandler Overweight
2022-08-03 ダウングレード Evercore ISI Outperform → In-line
2022-08-03 ダウングレード Guggenheim Buy → Neutral
2022-07-28 開始されました Wells Fargo Equal Weight
2022-02-09 ダウングレード SVB Leerink Mkt Perform → Underperform
2022-01-18 アップグレード RBC Capital Mkts Sector Perform → Outperform
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-07-20 アップグレード The Benchmark Company Hold → Buy
2021-02-10 ダウングレード SVB Leerink Mkt Perform → Underperform
2021-01-07 開始されました Truist Buy
2021-01-04 アップグレード Guggenheim Neutral → Buy
2020-06-16 開始されました The Benchmark Company Hold
2020-05-06 ダウングレード JP Morgan Overweight → Neutral
2020-04-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-04-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-24 再開されました William Blair Outperform
2020-03-13 アップグレード BofA/Merrill Neutral → Buy
2020-02-04 再開されました BofA/Merrill Neutral
2020-01-03 繰り返されました BMO Capital Markets Market Perform
2020-01-03 ダウングレード Mizuho Buy → Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-10-03 開始されました Mizuho Buy
2019-09-12 開始されました BMO Capital Markets Market Perform
2019-09-05 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-09-05 アップグレード Oppenheimer Perform → Outperform
2019-05-21 開始されました Credit Suisse Neutral
2019-05-03 ダウングレード Barclays Overweight → Equal Weight
2019-04-11 開始されました Stifel Hold
2019-04-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-01-24 アップグレード William Blair Mkt Perform → Outperform
すべてを表示

Incyte Corp (INCY) 最新ニュース

pulisher
02:02 AM

This biotech made it through a 'time correction.' The charts say it could be time to buy - CNBC

02:02 AM
pulisher
09:00 AM

Can a trend reversal in Incyte Corporation lead to recovery2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com

09:00 AM
pulisher
07:34 AM

Can Incyte Corporation (ICY) stock attract analyst upgradesWeekly Investment Recap & Weekly Breakout Stock Alerts - newser.com

07:34 AM
pulisher
05:14 AM

What’s next for Incyte Corporation stock price2025 Trading Volume Trends & AI Driven Stock Reports - newser.com

05:14 AM
pulisher
04:54 AM

What risks investors should watch in Incyte Corporation stockWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com

04:54 AM
pulisher
02:37 AM

Will Incyte Corporation (ICY) stock see insider accumulationPortfolio Gains Summary & Real-Time Market Trend Scan - newser.com

02:37 AM
pulisher
Oct 22, 2025

Does Incyte Corporation show high probability of reboundPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Incyte: Strong Growth, Margin Expansion, And Low Valuation - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Multi asset correlation models including Incyte CorporationWeekly Profit Report & Growth Focused Entry Reports - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Will Incyte Corporation (ICY) stock enhance shareholder valueTrade Signal Summary & Intraday High Probability Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte Claims Sun Pharma's Alopecia Drug Launch Violates IP - Law360

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock among top earnings playsWeekly Volume Report & High Conviction Buy Zone Picks - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte Corp. Stock Underperforms Monday When Compared To Competitors - 富途牛牛

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte (INCY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Real time alert setup for Incyte Corporation performance2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock undervalued by metricsWeekly Trend Summary & Safe Capital Investment Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock dividend growth reliable2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Assessing Incyte’s Share Price After Recent FDA Approval and Strong 2024 Gains - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Are You Looking for a Top Momentum Pick? Why Incyte (INCY) is a Great Choice - sharewise.com

Oct 20, 2025
pulisher
Oct 20, 2025

Incyte to Report Third Quarter 2025 Financial Results on October 28 - MyChesCo

Oct 20, 2025
pulisher
Oct 20, 2025

Lobbying Update: $80,000 of INCYTE CORPORATION lobbying was just disclosed - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 19, 2025

Incyte (INCY) Reports Encouraging Clinical Trial Data at ESMO Co - GuruFocus

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte at ESMO Congress 2025: Strategic Focus on Tumor Programs - Investing.com

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte’s cancer drug candidates show promising results in trials - Investing.com

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma - The AI Journal

Oct 19, 2025
pulisher
Oct 18, 2025

What technical charts say about Incyte Corporation stockLong Setup & Long-Term Safe Investment Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Incyte Corporation stock a defensive play in 20252025 Big Picture & Reliable Entry Point Trade Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Bollinger, Credo, Ambarella, Cipher, Incyte: Insider Moves Unveiled! - TipRanks

Oct 18, 2025
pulisher
Oct 17, 2025

Is Incyte Corporation (ICY) stock a defensive play amid uncertaintyWeekly Trend Summary & Real-Time Volume Trigger Notifications - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

How Incyte Corporation stock performs in rising dollar environmentMarket Performance Summary & Proven Capital Preservation Tips - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

InvestingPro’s Fair Value model captures 63% gain in Incyte shares By Investing.com - Investing.com

Oct 17, 2025
pulisher
Oct 16, 2025

How Incyte Corporation stock responds to policy changesTrade Volume Report & Consistent Return Strategy Ideas - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Incyte (INCY) Stock Is Up, What You Need To Know - Barchart.com

Oct 16, 2025
pulisher
Oct 16, 2025

Incyte Corporation stock hits 52-week high at 88.78 USD - Investing.com

Oct 16, 2025
pulisher
Oct 15, 2025

Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism - MSN

Oct 15, 2025
pulisher
Oct 15, 2025

Can Incyte Corporation rally from current levels2025 Top Gainers & Reliable Price Breakout Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sjogren’s Syndrome Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Gilead Sciences, Incyte Corp, Novartis, GlaxoSmithKline, Janssen Research & Development, LLC - Barchart.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sjogren's Syndrome Market Insights Highlight Expanding - openPR.com

Oct 15, 2025
pulisher
Oct 15, 2025

Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis in Children Ages 2-11 - Yahoo

Oct 15, 2025
pulisher
Oct 15, 2025

Using Python tools to backtest Incyte Corporation strategiesMarket Movers & Fast Entry Momentum Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000 - The Globe and Mail

Oct 14, 2025
pulisher
Oct 14, 2025

Incyte stock price target raised to $76 from $68 at UBS on valuation By Investing.com - Investing.com South Africa

Oct 14, 2025
pulisher
Oct 14, 2025

Incyte stock price target raised to $76 from $68 at UBS on valuation - Investing.com India

Oct 14, 2025

Incyte Corp (INCY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Incyte Corp (INCY) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Denton Sheila A.
EVP & General Counsel
Oct 15 '25
Sale
85.13
277
23,581
26,569
$36.85
price up icon 0.03%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
大文字化:     |  ボリューム (24 時間):